Jump Financial, LLC Tricida, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$7.31 - $11.85 $125,001 - $202,635	17,100 New	17,100 $166,000
Q1 2022 May 12, 2022	SELL	$7.35 - $10.63 $172,725 - $249,805	-23,500 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$4.19 - $9.56 $98,465 - $224,660	23,500 New	23,500 $225,000
Q1 2021 May 17, 2021	SELL	$4.52 - $7.8 $76,840 - $132,600	-17,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.37 - $9.46 $74,290 - $160,820	17,000 New	17,000 $120,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.